[Clinical study of cefsulodin on Pseudomonas aeruginosa infections in otorhinolaryngology].
The clinical effect of cefsulodin (CFS) on Pseudomonas aeruginosa infections in otorhinolaryngology was studied in 10 patients. The overall clinical effectiveness was 80% (excellent 2, good 6, poor 2). Eradication rates of P. aeruginosa was 60%. No side effect and positive skin test were found in any cases. Examination of laboratory data before and after the administration revealed no abnormal findings in every cases.
D000328:Adult; D000368:Aged; D002441:Cefsulodin; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010033:Otitis Media / Q000188:drug therapy*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D013530:Surgical Wound Infection / Q000188:drug therapy
D002511:Cephalosporins; D002441:Cefsulodin